GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Chimera Investment Corp (NYSE:CIM) » Definitions » Sloan Ratio %

Chimera Investment (Chimera Investment) Sloan Ratio %

: -4.94% (As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Chimera Investment's Sloan Ratio for the quarter that ended in Dec. 2023 was -4.94%.

As of Dec. 2023, Chimera Investment has a Sloan Ratio of -4.94%, indicating the company is in the safe zone and there is no funny business with accruals.


Chimera Investment Sloan Ratio % Historical Data

The historical data trend for Chimera Investment's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimera Investment Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.28 -48.50 -15.56 -10.06 -4.94

Chimera Investment Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.06 -7.24 -2.57 -0.35 -4.94

Competitive Comparison

For the REIT - Mortgage subindustry, Chimera Investment's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chimera Investment Sloan Ratio % Distribution

For the REITs industry and Real Estate sector, Chimera Investment's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Chimera Investment's Sloan Ratio % falls into.



Chimera Investment Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Chimera Investment's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(126.104-213.269
-551.752)/12928.998
=-4.94%

Chimera Investment's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(126.104-213.269
-551.752)/12928.998
=-4.94%

Chimera Investment's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 57.366 (Mar. 2023 ) + 36.024 (Jun. 2023 ) + 2.17 (Sep. 2023 ) + 30.544 (Dec. 2023 ) = $126.1 Mil.
Chimera Investment's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 30.441 (Mar. 2023 ) + 106.819 (Jun. 2023 ) + 44.682 (Sep. 2023 ) + 31.327 (Dec. 2023 ) = $213.3 Mil.
Chimera Investment's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -82.009 (Mar. 2023 ) + -110.891 (Jun. 2023 ) + 367.865 (Sep. 2023 ) + 376.787 (Dec. 2023 ) = $551.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chimera Investment  (NYSE:CIM) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Chimera Investment has a Sloan Ratio of -4.94%, indicating the company is in the safe zone and there is no funny business with accruals.


Chimera Investment Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Chimera Investment's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chimera Investment (Chimera Investment) Business Description

Address
630 Fifth Avenue, Suite 2400, New York, NY, USA, 10111
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the largest share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares. A significant percentage of these securities are backed by properties in California. The company generates nearly all of its income from interest payments derived from its investments.
Executives
Miyun Sung officer: Chief Legal Officer 4-75 48TH AVENUE #705, LONG ISLAND CITY NY 11109
Sudhanshu Thakkar officer: Co-Chief Investment Officer 630 FIFTH AVENUE, SUITE 2400, NEW YORK NY 10111
Sandra Bell director C/O TIPTREE INC., 660 STEAMBOAT ROAD, 2ND FL, GREENWICH CT 06830
Subramaniam Viswanathan officer: Chief Financial Officer 103 HARDING AVE, EDISON NJ 08820
Kelley Kortman officer: Principal Accounting Officer 520 MADISON AVE, FL 32, NEW YORK NY 10022
Kevin Gerald Chavers director C/O CHIMERA INVESTMENT CORPORATION, 520 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Matthew Lambiase director, officer: Chief Exec. Officer and Pres. 1211 AVENUE OF THE AMERICAS, SUITE 2902, NEW YORK NY 10036
Kardis Phillip John Ii officer: Chief Legal Officer C/O CHIMERA INVESTMENT CORPORATION, 1211 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Choudhary Yarlagadda officer: Chief Operating Officer 1211 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Robert S Colligan officer: CFO 1211 AVENUE OF THE AMERICAS, STE 2902, NEW YORK NY 10036
Brian Patrick Reilly director 520 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Paul Donlin director 1211 AVENUE OF THE AMERICAS, SUITE 2902, NEW YORK NY 10036
Gerard Creagh director C/O DUFF & PHELPS CORPORATION, 55 EAST 52ND STREET, NEW YORK NY 10055
Mohit Marria officer: Chief Investment Officer 1211 AVENUE OF THE AMERICAS, STE 2902, NEW YORK NY 10036
Debra Still director 520 MADISON AVE, 32ND FL, C/O CHIMERA INVESTMENT CORPORATION, NEW YORK NY 10022